| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |